POLRMT
DNA-directed RNA polymerase, mitochondrial
Also known as: APOLMT, h-mtRPOL, MTRNAP, MTRPOL, RPOM_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O00411
- Gene
- POLRMT
- Ensembl
- ENSG00000099821
- Chromosome
- 19
- Canonical length
- 1230 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Mitochondria
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a mitochondrial DNA-directed RNA polymerase. The gene product is responsible for mitochondrial gene expression as well as for providing RNA primers for initiation of replication of the mitochondrial genome. Although this polypeptide has the same function as the three nuclear DNA-directed RNA polymerases, it is more closely related to RNA polymerases of phage and mitochondrial polymerases of lower eukaryotes. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1230 residues, UniProt reviewed canonical sequence.
>O00411|POLRMT
1 MSALCWGRGA AGLKRALRPC GRPGLPGKEG TAGGVCGPRR SSSASPQEQD QDRRKDWGHV
61 ELLEVLQARV RQLQAESVSE VVVNRVDVAR LPECGSGDGS LQPPRKVQMG AKDATPVPCG
121 RWAKILEKDK RTQQMRMQRL KAKLQMPFQS GEFKALTRRL QVEPRLLSKQ MAGCLEDCTR
181 QAPESPWEEQ LARLLQEAPG KLSLDVEQAP SGQHSQAQLS GQQQRLLAFF KCCLLTDQLP
241 LAHHLLVVHH GQRQKRKLLT LDMYNAVMLG WARQGAFKEL VYVLFMVKDA GLTPDLLSYA
301 AALQCMGRQD QDAGTIERCL EQMSQEGLKL QALFTAVLLS EEDRATVLKA VHKVKPTFSL
361 PPQLPPPVNT SKLLRDVYAK DGRVSYPKLH LPLKTLQCLF EKQLHMELAS RVCVVSVEKP
421 TLPSKEVKHA RKTLKTLRDQ WEKALCRALR ETKNRLEREV YEGRFSLYPF LCLLDEREVV
481 RMLLQVLQAL PAQGESFTTL ARELSARTFS RHVVQRQRVS GQVQALQNHY RKYLCLLASD
541 AEVPEPCLPR QYWEELGAPE ALREQPWPLP VQMELGKLLA EMLVQATQMP CSLDKPHRSS
601 RLVPVLYHVY SFRNVQQIGI LKPHPAYVQL LEKAAEPTLT FEAVDVPMLC PPLPWTSPHS
661 GAFLLSPTKL MRTVEGATQH QELLETCPPT ALHGALDALT QLGNCAWRVN GRVLDLVLQL
721 FQAKGCPQLG VPAPPSEAPQ PPEAHLPHSA APARKAELRR ELAHCQKVAR EMHSLRAEAL
781 YRLSLAQHLR DRVFWLPHNM DFRGRTYPCP PHFNHLGSDV ARALLEFAQG RPLGPHGLDW
841 LKIHLVNLTG LKKREPLRKR LAFAEEVMDD ILDSADQPLT GRKWWMGAEE PWQTLACCME
901 VANAVRASDP AAYVSHLPVH QDGSCNGLQH YAALGRDSVG AASVNLEPSD VPQDVYSGVA
961 AQVEVFRRQD AQRGMRVAQV LEGFITRKVV KQTVMTVVYG VTRYGGRLQI EKRLRELSDF
1021 PQEFVWEASH YLVRQVFKSL QEMFSGTRAI QHWLTESARL ISHMGSVVEW VTPLGVPVIQ
1081 PYRLDSKVKQ IGGGIQSITY THNGDISRKP NTRKQKNGFP PNFIHSLDSS HMMLTALHCY
1141 RKGLTFVSVH DCYWTHAADV SVMNQVCREQ FVRLHSEPIL QDLSRFLVKR FCSEPQKILE
1201 ASQLKETLQA VPKPGAFDLE QVKRSTYFFSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against POLRMT can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 66 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 66 nTPM
- testis: 64 nTPM
- liver: 40 nTPM
- heart muscle: 36 nTPM
- hippocampal formation: 27 nTPM
- cerebral cortex: 27 nTPM
Single-cell type
- late spermatids: 131 nCPM
- undifferentiated spermatogonia: 108 nCPM
- differentiating spermatogonia: 92 nCPM
- late primary spermatocytes: 54 nCPM
- early spermatids: 35 nCPM
- colonocytes: 32 nCPM
Immune cell
- naive B-cell: 6.3 nTPM
- gdT-cell: 6.2 nTPM
- NK-cell: 6 nTPM
- memory B-cell: 5.7 nTPM
- myeloid DC: 5.6 nTPM
- plasmacytoid DC: 5.4 nTPM
Brain region
- medulla oblongata: 40 nTPM
- white matter: 38 nTPM
- cerebral cortex: 36 nTPM
- pons: 34 nTPM
- thalamus: 33 nTPM
- cerebellum: 32 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about POLRMT.
Disease | AllUniProt
Conditions POLRMT is implicated in, by any mechanism.
- Combined oxidative phosphorylation deficiency 55 (COXPD55) MIM:619743
Disease | GeneticClinVar
17 pathogenic / likely-pathogenic of 474 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Combined oxidative phosphorylation deficiency 55
- Neurodevelopmental disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.94
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.87
- DepMap mean gene effect
- -0.54
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- mitochondrial DNA replication
- mitochondrial transcription
- transcription initiation at mitochondrial promoter
Molecular functions
- 3'-5'-RNA exonuclease activity
- DNA-directed RNA polymerase activity
- mitochondrial promoter sequence-specific DNA binding
- RNA binding
- sequence-specific DNA binding
Cellular components
- mitochondrial matrix
- mitochondrial nucleoid
- mitochondrion
- protein-containing complex
- mitochondrial DNA-directed RNA polymerase complex
Protein domainsUniProt · Pfam · InterPro
- Tetratricopeptide-like helical domain superfamily
- DNA/RNA polymerase superfamily
- DNA-directed RNA polymerase, phage-type
- DNA-directed RNA polymerase, N-terminal
- DNA-directed RNA polymerase, N-terminal domain superfamily
- DNA-directed RNA polymerase, C-terminal domain, phage-type
- DNA-dependent RNA polymerase
- DNA-directed RNA polymerase N-terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of POLRMT in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads POLRMT as an antibody target. Whether an autoantibody or antibody against POLRMT could matter depends on whether native POLRMT is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
POLRMT is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label POLRMT as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...